This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
GenMark Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, commercializes, sells, and supports instruments and molecular tests based on its proprietary eSensor detection technology.View GNMK
GenMark Diagnostics Inc - GNMK - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates GenMark Diagnostics Inc as a
Sell with a ratings score of D.
Report Snippet: We rate GENMARK DIAGNOSTICS INC (GNMK) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow, feeble growth in its earnings per share and generally disappointing historical performance in the stock itself.